Related Experiment Video
Updated: Jun 2, 2026

Isolation of Rat Portal Fibroblasts by In situ Liver Perfusion
Published on: June 29, 2012
Liver fibrogenic cells
Stuart J Forbes1, Maurizio Parola
1MRC Centre for Regenerative Medicine, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK. sforbes2@staffmail.ed.ac.uk
Abstract:
Liver fibrogenic cells are a heterogenous population of cells that include α-smooth muscle actin positive myofibroblasts (MFs). MFs promote the progression of chronic liver diseases (CLDs) towards cirrhosis. MFs are highly proliferative and contractile and promote fibrogenesis by means of their multiple phenotypic responses to injury. These include: excess deposition and altered remodelling of extracellular matrix; the synthesis and release of growth factor which sustain and perpetuate fibrogenesis; chronic inflammatory response and neo-angiogenesis. MFs mainly originate from hepatic stellate cells or portal fibroblasts through activation and transdifferentiation. MFs may also potentially differentiate from bone marrow-derived stem cells. It has been suggested that MFs can be derived from hepatocytes or cholangiocytes through a process of epithelial to mesenchymal transition in the liver, however this is controversial. Hepatic MFs may also modulate the immune responses to hepatocellular carcinomas and metastatic cancers through cross talk with hepatic progenitor and tumour cells.
Insights
Myofibroblasts (MFs) drive chronic liver disease progression and cirrhosis by promoting fibrogenesis. These cells, originating from hepatic stellate cells and portal fibroblasts, contribute to excess matrix deposition and inflammation.
Area of Science:
- Cell Biology
- Hepatology
- Immunology
Background:
- Myofibroblasts (MFs) are key fibrogenic cells in chronic liver diseases (CLDs).
- MFs contribute to liver fibrosis progression and cirrhosis.
- Their heterogeneity and origins are crucial for understanding liver pathobiology.
Purpose of the Study:
- To elucidate the multifaceted roles of myofibroblasts in liver fibrogenesis.
- To explore the origins and phenotypic plasticity of hepatic myofibroblasts.
- To investigate the involvement of MFs in liver cancer immunology.
Main Methods:
- Review of literature on myofibroblast biology in liver disease.
- Analysis of cellular origins and activation pathways.
- Examination of MFs' interactions with extracellular matrix, growth factors, and immune cells.
Main Results:
- MFs exhibit diverse origins, primarily hepatic stellate cells and portal fibroblasts, with potential contributions from bone marrow stem cells.
- MFs promote fibrogenesis through matrix deposition, growth factor release, inflammation, and neo-angiogenesis.
- Hepatic MFs modulate immune responses in hepatocellular carcinoma and metastatic liver cancer.
Conclusions:
- MFs are central drivers of liver fibrosis and cirrhosis.
- Understanding MFs' origins and functions is critical for therapeutic strategies.
- MFs play a complex role in liver cancer immunity, warranting further investigation.
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cirrhosis II: Pathophysiology
Liver Histology
Hepatocytes perform a variety of essential functions. They secrete...
Introduction to Fibroblasts
Cirrhosis I: Introduction
Tissue Renewal without Stem Cells
However, failure of such a system...
